1028 related articles for article (PubMed ID: 9710446)
1. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
2. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
3. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
5. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma.
Seishima M; Oda M; Oyama Z; Yoshimura T; Yamazaki F; Aoki T; Nei M; Hashimoto T
Arch Dermatol; 2004 Dec; 140(12):1500-3. PubMed ID: 15611429
[TBL] [Abstract][Full Text] [Related]
6. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
[TBL] [Abstract][Full Text] [Related]
7. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
9. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
10. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
11. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
12. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
13. Development of an enzyme-linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus.
Nishifuji K; Tamura K; Konno H; Olivry T; Amagai M; Iwasaki T
Vet Dermatol; 2009 Oct; 20(5-6):331-7. PubMed ID: 20178469
[TBL] [Abstract][Full Text] [Related]
14. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.
Nagasaka T; Nishifuji K; Ota T; Whittock NV; Amagai M
J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999
[TBL] [Abstract][Full Text] [Related]
15. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity against desmosomal cadherins in pemphigus.
Amagai M
J Dermatol Sci; 1999 Jun; 20(2):92-102. PubMed ID: 10379702
[TBL] [Abstract][Full Text] [Related]
17. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.
Amagai M; Hashimoto T; Shimizu N; Nishikawa T
J Clin Invest; 1994 Jul; 94(1):59-67. PubMed ID: 8040292
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
Bouloc A; Joly P; Saint-Leger E; Wechsler J; Roujeau JC; Revuz J
J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]